XML 20 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash Flows — Operating Activities    
Net Cash Provided by Operating Activities $ 39,761 $ 32,293
Cash Flows — Investing Activities    
Funding and advances for build-to-suit projects (30,514) (54,001)
Acquisitions of real estate and direct financing leases (27,687) (55,328)
Value added taxes refunded in connection with acquisitions of real estate 12,050 2,814
Capital contributions to equity investment (5,616) (3,596)
Change in investing restricted cash 3,480 579
Capital expenditures on real estate (3,089) (3,410)
Payment of deferred acquisition fees to an affiliate (2,854) (3,409)
Value added taxes paid in connection with acquisition of real estate (2,491) (4,687)
Return of capital from equity investments 236 2,175
Other investing activities, net (38) 37
Deposits for investments 0 4,000
Proceeds from sale of real estate 0 40
Net Cash Used in Investing Activities (56,523) (114,786)
Cash Flows — Financing Activities    
Distributions paid (42,210) (40,334)
Proceeds from mortgage financing 32,613 72,290
Proceeds from issuance of shares 21,175 20,166
Proceeds from notes payable to affiliate 11,196 0
Distributions to noncontrolling interests (8,261) (8,077)
Repurchase of shares (7,349) (5,162)
Scheduled payments and prepayments of mortgage principal (6,323) (1,526)
Repayment of notes payable to affiliate (4,495) 0
Contributions from noncontrolling interests 2,339 41
Payment of deferred financing costs and mortgage deposits (526) (798)
Change in financing restricted cash (30) 4,941
Other financing activities, net (13) 0
Net Cash (Used in) Provided by Financing Activities (1,884) 41,541
Change in Cash and Cash Equivalents During the Period    
Effect of exchange rate changes on cash and cash equivalents 2,167 411
Net decrease in cash and cash equivalents (16,479) (40,541)
Cash and cash equivalents, beginning of period 72,028 117,453
Cash and cash equivalents, end of period $ 55,549 $ 76,912